Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides. | Int J Pharm | 2021 | 33640427 | PubTator, text mining | PubMed |
| Neonatal PURA syndrome: a case report and literature review. | Transl Pediatr | 2021 | 33633953 | PubTator, text mining | PubMed |
| Biallelic variants in COPB1 cause a novel, severe intellectual disability syndrome with cataracts and variable microcephaly. | Genome Med | 2021 | 33632302 | PubTator, text mining | PubMed |
| Risdiplam in Type 1 Spinal Muscular Atrophy. | N Engl J Med | 2021 | 33626251 | PubTator, text mining | PubMed |
| Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study. | Neurotherapeutics | 2021 | 33624184 | PubTator, text mining | PubMed |
| Successful weaning from mechanical ventilation in a patient with SMA type 1 treated with nusinersen. | Ann Clin Transl Neurol | 2021 | 33616311 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study. | J Cell Mol Med | 2021 | 33609080 | PubTator, text mining | PubMed |
| DDX21 interacts with nuclear AGO2 and regulates the alternative splicing of SMN2. | Biosci Biotechnol Biochem | 2021 | 33604619 | PubTator, text mining | PubMed |
| Antisense technology: A review. | J Biol Chem | 2021 | 33600796 | PubTator, text mining | PubMed |
| Nuisance compounds in cellular assays. | Cell Chem Biol | 2021 | 33592188 | PubTator, text mining | PubMed |
| U7 snRNA: A tool for gene therapy. | J Gene Med | 2021 | 33590603 | PubTator, text mining | PubMed |
| Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy. | Mol Ther Nucleic Acids | 2021 | 33575118 | PubTator, text mining | PubMed |
| Nusinersen in spinal muscular atrophy type 1 from neonates to young adult: 1-year data from three Asia-Pacific regions. | J Neurol Neurosurg Psychiatry | 2021 | 33574081 | PubTator, text mining | PubMed |
| Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland. | Neurol Neurochir Pol | 2021 | 33565602 | PubTator, text mining | PubMed |
| Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. | Int J Mol Sci | 2021 | 33562713 | PubTator, text mining | PubMed |
| In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy. | Brain Sci | 2021 | 33562482 | PubTator, text mining | PubMed |
| SCID newborn screening: What we've learned. | J Allergy Clin Immunol | 2021 | 33551023 | PubTator, text mining | PubMed |
| Type I SMA "new natural history": long-term data in nusinersen-treated patients. | Ann Clin Transl Neurol | 2021 | 33547876 | PubTator, text mining | PubMed |
| Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy. | Sci Rep | 2021 | 33542429 | PubTator, text mining | PubMed |
| SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing. | Theranostics | 2021 | 33537092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=69